During morning rounds, a nurse observes that a 65-year-old client with a history of alcoholic liver disease has become increasingly lethargic, is disoriented to place, and demonstrates a flapping tremor when arms are extended. To manage the underlying physiological cause of this clinical deterioration, which priority action should the nurse take?

Lactulose is the priority as it directly reduces ammonia, the underlying cause of hepatic encephalopathy. Other options address symptoms (monitoring), long-term management (protein restriction), or complications (paracentesis) but do not treat the immediate cause.

Clinical Presentation and Pathophysiology
The client’s history of alcoholic liver disease, progressive lethargy, disorientation, and the presence of a flapping tremor (asterixis) strongly suggest a diagnosis of overt hepatic encephalopathy (HE). HE is a neuropsychiatric complication of advanced liver disease and cirrhosis, resulting from the liver’s inability to clear gut-derived neurotoxins, primarily ammonia, from the portal circulation. Hyperammonemia is widely regarded as the central hallmark of HE pathogenesis, as ammonia crosses the blood-brain barrier and causes astrocyte swelling and cerebral dysfunction, leading to the spectrum of symptoms from subtle cognitive impairment to coma ^[3]. In cirrhosis, HE is an independent predictor of morbidity and mortality, and its emergence signals a critical clinical deterioration that requires immediate intervention targeting the underlying biochemical cause ^[3].

Priority Action and Pharmacological Rationale
The priority action is to administer prescribed lactulose as ordered. Lactulose is the established first-line therapy for the treatment of an acute episode of overt HE ^[1]. Its mechanism of action directly addresses the underlying hyperammonemia through several pathways in the gastrointestinal tract. It acidifies the colonic lumen, which converts freely diffusible ammonia (NH₃) into ammonium ions (NH₄⁺) that are trapped in the gut and cannot be reabsorbed into the bloodstream. Additionally, its cathartic effect accelerates bowel transit, reducing the time for bacterial production and absorption of ammonia and other nitrogenous wastes. A systematic review and meta-analysis of randomized controlled trials confirms lactulose’s efficacy as the primary treatment for HE, supporting its use to reverse the neuropsychiatric deterioration observed in this client ^[1].

Analysis of Incorrect Options
- Option 1 (Monitor neurological status and implement safety measures): While monitoring and safety interventions are essential nursing actions for a disoriented client at risk for falls, they are supportive measures that do not address the physiological cause of the deterioration. Managing the underlying hyperammonemia takes precedence to halt and reverse the pathological process.
- Option 3 (Restrict dietary protein intake): Historically, protein restriction was advised, but current understanding recognizes that malnutrition is a significant risk factor for poor outcomes in cirrhosis. Precipitating factors for HE recurrence include constipation and dehydration, not simply protein intake . Protein restriction is no longer a first-line or priority intervention for an acute HE episode, as it can worsen sarcopenia without clear benefit in resolving the acute neurotoxicity.
- Option 4 (Prepare for potential paracentesis procedure): Paracentesis is a therapeutic procedure for removing ascitic fluid, a common complication of cirrhosis. However, it does not treat the metabolic cause of hepatic encephalopathy. Unless the HE was precipitated by spontaneous bacterial peritonitis (which is not indicated in the scenario), paracentesis is not the priority action for managing the client’s neurological and cognitive decline.

Clinical Integration
The nurse must recognize that the constellation of symptoms represents a life-threatening, but potentially reversible, metabolic encephalopathy. Administering the prescribed lactulose is the critical action to lower serum ammonia levels and resolve the encephalopathy. This intervention directly targets the central pathophysiological mechanism of the condition, making it the highest priority over supportive or unrelated procedures ^[1][3].